A zotarolimus-eluting stent coated with BioLinx, a biocompatible proprietary polymer blend with hydrophilic and noninflammatory properties, designed to extend the delivery time of zotarolimus to the vessel wall to treat complex lesions that may have delayed healing time and greater prolonged risk for restenosis.

If you have a Hayes login, click here to view the full report on the Knowledge Center.